Eden review
A polished, high-disclosure compounded program with strong nationwide coverage.
Eden — FDA warning letter, June 2026. Addressed to Eden Health International Inc. dba Eden, and public in FDA’s warning-letter database.
- Semaglutide
- $239/mo
- Tirzepatide
- $349/mo
- Coverage
- All 50 states
- Brand-name
- Compounded only
The scorecard
Eden scored on our six published factors. See the methodology.
What we like
- High verification confidence — clear supply-chain and clinician disclosure
- Nationwide availability
- Both molecules offered
The caveats
- Premium pricing vs the cheapest tiers
- Compounded only — no brand-name access
- FDA issued a warning letter to Eden Health International Inc. dba Eden in June 2026; it is public in FDA's warning-letter database
The verdict
Best for: People who prioritize a vetted, high-transparency provider over the lowest sticker price. A polished, high-disclosure compounded program with strong nationwide coverage.
Ranked #2 of 539 providers we have reviewed — for comparison, read our ruling on CoreAge Rx, our #1 pick. In the ranking it sits between CoreAge Rx at #1, 94/100 above and Sesame Care at #3, 87/100 below, with the ShedRx ruling the next one down.
Weighing it against something else? Every provider we would put in front of Eden is ranked on price honesty, prescriber access and cancellation terms.This ruling sits inside a bigger one: the complete ranking puts this ruling in context against every program we track. We have also ruled on it directly: CoreAge Rx vs Eden goes to CoreAge Rx, 94/100 to 91/100. The other call worth reading is Eden against Sesame Care, a 4-point call. We have also ruled on Eden against ShedRx, which goes to Eden, 91/100 to 87/100. We have also ruled on Eden against Ondra Health, which goes to Eden, 91/100 to 89/100.
Compare with other providers
The closest rulings to Eden by Verdict Score — the realistic shortlist if you are weighing this one up.
- #1CoreAge Rx— The most honest middle of the market: nationwide access, both molecules at one flat, no-surprise price.94/100
- #3Sesame Care— An established national telehealth marketplace carrying real brand-name GLP-1s — Wegovy (pen and pill), Zepbound, Ozempic and Mounjaro — where most programs we rank carry none, plus provider-by-provider price transparency.87/100
- #4ShedRx— Four routes to the same molecule — injection, drops, lozenges and an oral pill — plus real brand Zepbound, with health coaching bundled in.87/100
- #5Ondra Health— A rare combination: near-cheapest semaglutide, nationwide reach, brand-name access and a LegitScript-verified operation.89/100
- #6Sprout Health— A LegitScript-certified desk that pairs low-cost compounded semaglutide and tirzepatide with a real brand-name Wegovy and Zepbound path — carrying an FDA warning letter from September 2025.86/100
- #7Gala Health— A cheap compounded entry with a real brand-Ozempic path and nationwide coverage — but the $179 is a yearly-subscription rate, and Gala publishes no month-to-month price at all, which is what the verdict now docks it hardest for.86/100
Pricing, states and verification reflect Eden's public disclosures at last review; the Verdict Score is our editorial judgment per the methodology. Prices change — confirm on Eden's site. Not medical advice; see our disclosure.